Investor Relations

Investor Relations

Corporate Profile

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders. We commercialize a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.

Our prescription WatchPAT family of products, which utilizes the PAT signal, is designed to enable patients suspected to have sleep related breathing disorders to easily conduct sleep apnea tests in the comfort of their homes in accordance with a physician’s instructions, as authorized by qualified medical personnel while delivering the treating physicians with comprehensive, accurate and reliable results to aid in the diagnosis of sleep apnea.

 
Stock Information
Press Releases
Nov
2020
Itamar Medical to Participate in the Piper 32nd Annual Virtual Healthcare Conference
Nov
2020
Itamar Medical Announces Preliminary Results from Two Large Claims Database Studies Demonstrating Significant Health Economic Benefits of Effective Sleep Apnea Management for Cardiovascular Patients
Nov
2020
Itamar Medical Reports Record Third Quarter 2020 Revenues
Nov
2020
Itamar Medical to Report Third Quarter Financial Results and Host Conference Call on Tuesday, November 17, 2020
Oct
2020
Itamar Medical Announces Appointment of Shane Brown as President – U.S.
Oct
2020
Itamar™ Medical Announces Third Quarter Preliminary Revenue Results and Reinstates Revenue Guidance for Full Year 2020
Investor Events
Dec
2020
Piper Virtual Healthcare Conference
Nov
2020
Q3 2020 Itamar Medical Ltd. Earnings Conference Call
Sep
2020
H.C. Wainwright 22nd Annual Global Investment Conference
Aug
2020
Notice of annual shareholders meeting
Investor Presentations
Management